Stocks and Investing
Stocks and Investing
Tue, March 14, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, March 13, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Steven Zaccone Downgraded (WOOF) to Hold and Held Target at $11 on, Mar 13th, 2023
Steven Zaccone of Citigroup, Downgraded "Petco Health and Wellness Company, Inc." (WOOF) to Hold and Held Target at $11 on, Mar 13th, 2023.
Steven has made no other calls on WOOF in the last 4 months.
There are 6 other peers that have a rating on WOOF. Out of the 6 peers that are also analyzing WOOF, 2 agree with Steven's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Simeon Gutman of "Morgan Stanley" Maintained at Hold with Decreased Target to $12 on, Tuesday, January 17th, 2023
- Michael Lasser of "UBS" Maintained at Hold with Decreased Target to $12 on, Thursday, December 1st, 2022
These are the ratings of the 4 analyists that currently disagree with Steven
- Steven Shemesh of "RBC Capital" Reiterated at Buy and Held Target at $14 on, Thursday, February 9th, 2023
- Kate McShane of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $16 on, Thursday, December 1st, 2022
- Anna Andreeva of "Needham" Maintained at Strong Buy with Decreased Target to $20 on, Monday, November 28th, 2022
- Zachary Fadem of "Wells Fargo" Maintained at Buy with Decreased Target to $14 on, Friday, November 18th, 2022
Contributing Sources